Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
5 Oct 2026
Lecanemab Linked to Plasma Biomarker Changes in Alzheimer's Disease
Lecanemab was linked to multidirectional shifts in plasma biomarkers of Alzheimer’s disease. See which markers normalised and which moved the other way.
5 Oct 2026
Nomograms Predict Survival in Rare Prostate Cancer
Rare prostate cancer nomograms demonstrated strong predictive performance for one-, three-, and five-year overall and cancer-specific survival.
5 Oct 2026
Paediatric Dermatology Quality of Life Tool Passes Validation
A validated Amharic pediatric dermatology quality of life tool reliably tracked disease burden and treatment response.
1
Mins
5 Oct 2026
Hema Now: How Close Are We to Transforming Myeloma Care?
In this episode of Hema Now, we sit down with internationally recognised myeloma expert Ola Landgren. He shares his career journey, the…
4 Oct 2026
COVID-19 Linked to Increased Risk of Six Allergic Conditions
COVID-19 infection was associated with increased risks of six allergic conditions over 18 months. Findings differed in children and active-duty service members, highlighting a potential burden of allergic disease after infection.
4 Oct 2026
TB Preventive Treatment Protection Varies by Disease Burden
TB preventive treatment remained protective for years, but durability varied substantially by disease burden.
4 Oct 2026
Infection-Related Cancers Cause One in Eight Cases Globally
Carcinogenic infections caused approximately 2.3 million invasive cases worldwide during 2024, representing one in eight diagnoses.
4 Oct 2026
Machine Learning Improves Colorectal Cancer Recurrence Prediction
Machine learning models predicted site-specific recurrence and overall survival in patients with colorectal cancer liver metastases after hepatectomy.
4 Oct 2026
Targeting Neuroinflammation with Low-Dose IL-2 for ALS Shows Promise
Adjunctive low-dose IL-2 for ALS significantly improved overall survival while reducing functional decline across targeted cohorts.
4 Oct 2026
Pembrolizumab-Olaparib Delays Ovarian Cancer Progression
Pembrolizumab–olaparib reduced progression risk in advanced BRCA non-mutated ovarian cancer.
←
1
2
3
…
66
67
68
69
70
71
72
…
1,854
1,855
1,856
→
We’ve noticed you’re accessing
from
North/South America.
View
View